{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T21:57:24Z","timestamp":1793656644170,"version":"4.5.1"},"reference-count":32,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T00:00:00Z","timestamp":1780358400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>In 2023, Nigeria introduced the Human Papillomavirus (HPV) vaccine into routine immunization to reduce the high burden of cervical cancer. However, limited evidence exists regarding early vaccine availability, uptake, and the contextual factors influencing implementation across health facilities.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This study employed a sequential explanatory mixed-methods design (quan + QUAL) across five Nigerian states (Oyo, Jigawa, Kano, Lagos, and Rivers). Data collectors conducted monthly visits to assess HPV vaccine availability and reviewed the facility register to assess HPV vaccine uptake. Subsequently, in-depth interviews were conducted with healthcare workers to explore contextual determinants of vaccine delivery and acceptance. Qualitative data were analyzed using reflexive thematic analysis and reported in accordance with COREQ guidelines.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Result<\/jats:title>\n                    <jats:p>Overall, 13 of the 52 (25%) facilities included in this study did not record a single HPV vaccine availability and uptake throughout the entire 4\u202fmonths period. HPV vaccine availability varied substantially across states and facilities, with only 8\/17 facilities in Oyo reporting availability compared to 6\/11 in Jigawa across all 4\u202fmonths. Uptake also varied widely, ranging from 0 to 308 doses per facility over the 4\u202fmonths, with higher uptake observed in parts of Rivers State. Qualitative themes supported these findings, demonstrating that HPV vaccine uptake evolved as communities increasingly understood its relevance through local narratives, trusted health worker endorsement, and peer influence. Despite a structured rollout, frontline preparedness and vaccine uptake were shaped by variability in training, outreach-driven delivery, trust in healthcare workers and community influencers, as well as sociocultural barriers, misconceptions, and household power dynamics.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Overall, our study reinforces that improving HPV vaccine coverage requires more than expanding stock; it demands reliable access, responsive service delivery models, and socially grounded communication strategies that foster community legitimacy. Addressing both structural constraints and contextual determinants will be essential to prevent HPV vaccination from remaining concentrated in a few facilities and instead embed it as a routine, equitable public health intervention.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fpubh.2026.1834756","type":"journal-article","created":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T15:49:16Z","timestamp":1780415356000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Early implementation and contextual determinants of the human papillomavirus vaccine rollout and uptake in Nigeria: a mixed-methods study"],"prefix":"10.3389","volume":"14","author":[{"given":"Gbemisola T.","family":"Olubayo","sequence":"first","affiliation":[{"name":"Department of Community Medicine, University College Hospital","place":["Ibadan, Nigeria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayodamola","family":"Bakare","sequence":"additional","affiliation":[{"name":"Oxygen for Life Initiative","place":["Ibadan, Nigeria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julius","family":"Salako","sequence":"additional","affiliation":[{"name":"Oxygen for Life Initiative","place":["Ibadan, Nigeria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olumide E.","family":"Olufayo","sequence":"additional","affiliation":[{"name":"Oxygen for Life Initiative","place":["Ibadan, Nigeria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayobami A.","family":"Bakare","sequence":"additional","affiliation":[{"name":"Department of Community Medicine, University College Hospital","place":["Ibadan, Nigeria"]},{"name":"Department of Global Public Health, Karolinska Institutet (KI)","place":["Solna, Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,2]]},"reference":[{"key":"ref1","year":"2025"},{"key":"ref2","year":"2025"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"e2300088","DOI":"10.1200\/GO.23.00088","article-title":"Spotlight on human papillomavirus vaccination coverage: is Nigeria making any progress?","author":"Okolie","year":"2023","journal-title":"JCO Glob Oncol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1186\/s12879-022-07215-7","article-title":"Prevalence of vaginal HPV infection among adolescent and early adult girls in Jos, north-Central Nigeria","volume":"22","author":"Cosmas","year":"2022","journal-title":"BMC Infect Dis"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"e90912","DOI":"10.1371\/journal.pone.0090912","article-title":"Knowledge and awareness of HPV vaccine and acceptability to vaccinate in sub-Saharan Africa: a systematic review","volume":"9","author":"Perlman","year":"2014","journal-title":"PLoS One"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"25","DOI":"10.9734\/ijtdh\/2020\/v41i830308","article-title":"Human papilloma virus transmission: knowledge and uptake of HPV vaccine among in-school adolescent girls in south-South Nigeria","volume":"1","author":"Ojule","year":"2020","journal-title":"Int J Trop Dis Health"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1016\/S0140-6736(23)02450-9","article-title":"Nigeria targets almost 8 million girls with HPV vaccine","volume":"402","author":"Adepoju","year":"2023","journal-title":"Lancet"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"108","DOI":"10.29063\/ajrh2023\/v27i3.12","article-title":"Knowledge, attitude, and uptake of human papilloma virus (HPV) vaccine among parents of adolescents attending outpatient clinic at the University of Benin Teaching Hospital, Nigeria","volume":"27","author":"Elebiyo","year":"2023","journal-title":"Afr J Reprod Health"},{"key":"ref9","year":"2024"},{"key":"ref10","year":"2026"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1080\/2159676X.2019.1628806","article-title":"Reflecting on reflexive thematic analysis","volume":"11","author":"Braun","year":"2019","journal-title":"Qual Res Sport, Exerc Health"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1093\/intqhc\/mzm042","article-title":"Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups","volume":"19","author":"Tong","year":"2007","journal-title":"Int J Qual Health Care"},{"key":"ref13","year":"2025"},{"key":"ref14","year":"2025"},{"key":"ref15","year":"2022"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"48","DOI":"10.4274\/jtgga.galenos.2022.2022-6-6","article-title":"Barriers to the HPV vaccination program in the eastern Mediterranean region: a narrative review","volume":"24","author":"Hakimi","year":"2023","journal-title":"J Turk Ger Gynecol Assoc"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.3332\/ecancer.2024.1735","article-title":"Addressing HPV vaccine hesitancy: unveiling concerns and building trust perspectives of adolescent girls and parents in Kisumu County, Kenya","volume":"18","author":"Ochomo","year":"2024","journal-title":"Ecancermedicalscience"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/s12889-020-8302-z","article-title":"Health system factors influencing uptake of human papilloma virus (HPV) vaccine among adolescent girls 9-15 years in Mbale District, Uganda","volume":"20","author":"Nabirye","year":"2020","journal-title":"BMC Public Health"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1186\/s12913-022-08224-7","article-title":"Facilitators and barriers of healthcare workers\u2019 recommendation of HPV vaccine for adolescents in Nigeria: views through the lens of theoretical domains framework","volume":"22","author":"Balogun","year":"2022","journal-title":"BMC Health Serv Res"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1136\/sextrans-2025-056496","article-title":"Community engagement for HPV vaccination in Nigeria","volume":"101","author":"Bamogo","year":"2025","journal-title":"Sex Transm Infect"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1093\/heapol\/czaa017","article-title":"Health systems constraints and facilitators of human papillomavirus immunization programmes in sub-Saharan Africa: a systematic review","volume":"35","author":"Amponsah-Dacosta","year":"2020","journal-title":"Health Policy Plan"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1186\/s12905-023-02345-9","article-title":"Cervical cancer screening and vaccination: knowledge, awareness, and attitude of female staff in a Nigerian university","volume":"23","author":"Ogundipe","year":"2023","journal-title":"BMC Womens Health"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1186\/s12889-025-22000-2","article-title":"Predictors of willingness of HPV vaccine uptake across eight states in Nigeria","volume":"25","author":"Okagbue","year":"2025","journal-title":"BMC Public Health"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"e000003","DOI":"10.1136\/bmjph-2023-000003","article-title":"Examining barriers and facilitators of HPV vaccination in Nigeria, in the context of an innovative delivery model: a mixed-methods study","volume":"1","author":"Talabi","year":"2023","journal-title":"BMJ Public Health"},{"key":"ref25","author":"Johnson","year":"2024"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"2429894","DOI":"10.1080\/21645515.2024.2429894","article-title":"Acceptance of human papillomavirus vaccine among boys in Asia: a narrative review","volume":"20","author":"Fu","year":"2024","journal-title":"Hum Vaccin Immunother"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1186\/s12889-023-15842-1","article-title":"Barriers and facilitators of HPV vaccination in sub-saharan Africa: a systematic review","volume":"23","author":"Kutz","year":"2023","journal-title":"BMC Public Health"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1186\/s12889-026-26730-9","article-title":"Perceptions of a gender-neutral approach to human papillomavirus (HPV) vaccination in Cameroon: a qualitative study","volume":"26","author":"Iliassu","year":"2026","journal-title":"BMC Public Health"},{"key":"ref29","author":"Biriowo","year":"2024"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1186\/s12982-025-01276-0","article-title":"Perceptions of HPV and HPV vaccines among parents and caregivers of girls aged 9\u201314 years in Nigeria: a qualitative study","volume":"22","author":"Asaolu","year":"2025","journal-title":"Discov Public Health"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1186\/s12889-017-4020-6","article-title":"Factors affecting the implementation of childhood vaccination communication strategies in Nigeria: a qualitative study","volume":"17","author":"Oku","year":"2017","journal-title":"BMC Public Health"},{"key":"ref32","author":"Olajire","year":"2025"}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2026.1834756\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T15:49:17Z","timestamp":1780415357000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2026.1834756\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,2]]},"references-count":32,"alternative-id":["10.3389\/fpubh.2026.1834756"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2026.1834756","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,2]]},"article-number":"1834756"}}